Concepedia

Christine Fazenbaker

CF

20

Publications

866

Citations

18

H-Index

2001

Active since

Affiliations

Altimmune (United States)(Current)

University of California, Santa Barbara

AstraZeneca (United States)

Spirogen (United Kingdom)

Christine Fazenbaker is an author at Altimmune (United States) specializing in medicine, radiation oncology, and pharmacology.

ORCID

Top concepts

Publications per year

2001–2023

20

Publications

20

A Human Antibody–Drug Conjugate Targeting EphA2 Inhibits Tumor Growth<i>In vivo</i>

Dowdy Jackson, John Gooya, Shenlan Mao et al. · Cancer Research · 2008 · 148 citations · Full text

EphA2 Immunoconjugate as Molecularly Targeted Chemotherapy for Ovarian Carcinoma

Jeong‐Won Lee, Hee Dong Han, Mian M.K. Shahzad et al. · JNCI Journal of the National Cancer Institute · 2009 · 89 citations · Full text

Efficient Preparation of Site-Specific Antibody–Drug Conjugates Using Cysteine Insertion

Nazzareno Dimasi, Ryan Fleming, Haihong Zhong et al. · Molecular Pharmaceutics · 2017 · 74 citations

Preclinical modeling of improved amifostine (ethyol) use in radiation therapy

David R. Cassatt, Christine Fazenbaker, Christine M. Bachy et al. · Seminars in Radiation Oncology · 2002 · 73 citations

, , +5

Tuning the Diels–Alder Reaction for Bioconjugation to Maleimide Drug-Linkers

André H. St. Amant, Daniel Lemen, Stelios Florinas et al. · Bioconjugate Chemistry · 2018 · 68 citations

Rows per page

1–5 of 20